Myocardial infarction (MI) is a major disease posing a significant threat to human health, as it
leads to necrosis of numerous cardiomyocytes (CMs), left ventricle dilation, and cardiac …

The inflammatory response to chronic injury affects tissue regeneration and has become an
important factor influencing the prognosis of patients. In previous stem cell treatments, it was …

Abstract Rationale: Extracellular vesicles (EVs) from mesenchymal stromal cell (MSC) are a
potential therapy for cardiac healing after myocardial infarction (MI). Nevertheless, neither …

The degree of tissue injuries such as the level of scarring or organ dysfunction, and the
immune response against them primarily determine the outcome and speed of healing …

Ecto-5′-nucleotidase [cluster of differentiation 73 (CD73)] is a ubiquitously expressed
glycosylphosphatidylinositol-anchored glycoprotein that converts extracellular adenosine …

Mesenchymal stem cells (MSC) are not universal and may be subject to dynamic changes
upon local milieus in vivo and after isolation and cultivation in vitro. Here, we demonstrate …

Biomaterials have long been the focus of research and hydrogels are representatives
thereof. Hydrogels have attracted much attention in the medical sciences, especially as a …

Despite the progress of cardiovascular medicine, ischemia-reperfusion injury can contribute
to increased mortality and prolonged hospitalization after myocardial infarction. Ischemia …

Mesenchymal stem cells (MSCs), as a kind of pluripotent stem cells, have attracted much
attention in orthopedic diseases, geriatric diseases, metabolic diseases, and sports …

Cardiovascular disease usually triggers coronary heart disease, stroke, and ischemic
diseases, thus promoting the development of functional failure. Mesenchymal stem cells …